-A +A

June 2011 Newsletter

In 1912, a young scientist working in the University of Munich Department of Psychiatry made a discovery that would simultaneously transform our understanding of dementia and lead to great confusion among patients, family members, and even medical professionals.

Dr. Hurtig has been a member of LBDA's Scientific Advisory Council for five years and served as chair of the planning committee for the Biomarkers in Lewy Body Disease Conference held in Washington, DC in 2010, which was jointly sponsored by LBDA and the National Institutes of Neurological Disorders in Stroke.

If you find social activities a difficult area of caregiving, perhaps considering the patient’s disabilities and limitations and how to respond appropriately will help. 

New research reveals promise of another brain imaging technique to differentiate between dementia with Lewy bodies (DLB) and Alzheimer’s disease (AD).